Multidrug-ResistantSalmonellaenterica4,[5],12:i:- Sequence Type 34, New South Wales, Australia, 2016–2017

• DOI: 10.3201/eid2404.171619
• Publication Date: 2018-02-28T14:11:48Z
• Authors: Alicia Arnott; Qinning Wang; Nathan Bachmann; Rosemarie Sadsad; Chayanika Biswas; Cristina Sotomayor; Peter Howard; Rebecca Rockett; Agnieszka Wiklendt; Jon R. Iredell; Vitali Sintchenko
• Keywords: Adult; salmonellosis; antibiotic resistance; Adolescent; 610; Infectious and parasitic diseases; RC109-216; molecular epidemiology; History, 21st Century; Young Adult; 03 medical and health sciences; Salmonella; Drug Resistance, Multiple, Bacterial; genomics; Humans; Child; Aged; Aged, 80 and over; 0303 health sciences; Whole Genome Sequencing; R; Dispatch; Infant, Newborn; Infant; Salmonella enterica; Middle Aged; 3. Good health; whole-genome sequencing; Child, Preschool; Salmonella Infections; Medicine; New South Wales; Genome, Bacterial; Multilocus Sequence Typing

Multidrug- and colistin-resistant Salmonella enterica serotype 4,[5],12:i:- sequence type 34 is present in Europe and Asia. Using genomic surveillance, we determined that this sequence type is also endemic to Australia. Our findings highlight the public health benefits of genome sequencing-guided surveillance for monitoring the spread of multidrug-resistant mobile genes and isolates.